LifeStance Health Group, Inc. Common Stock (LFST)
LifeStance Health Group, Inc. (LFST) is a provider of outpatient mental health services in the United States. The company offers a range of mental health care, including therapy, counseling, and medication management, delivered through a combination of in-person and virtual care. Established to expand access to behavioral health services, LifeStance operates numerous clinics across multiple states, focusing on improving mental health outcomes for individuals of all ages.
Company News
Presidio appointed Paula Cipollone as Chief Transformation Officer to lead strategic operations and drive AI-powered transformation, focusing on streamlining operations and enhancing customer engagement.
Wall Street analysts have set a mean price target of $7.93 for LifeStance Health, indicating a potential upside of 26.7%. However, investors should be cautious as price targets can be unreliable and analysts may have business incentives to set overly optimistic targets.
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
The company saw revenue climb by 29% in 2022.